FABP4 and diabetes mellitus: Elevated levels of circulating FABP4 have been proposed as a marker of DM-related syndrome (Rodríguez-Calvo et al., 2019), with a pro-diabetic impact in the process of diabetes in the pancreas (Xiao et al., 2021).